President-elect Trump's plan to impose tariffs on imported goods will affect the prices of the approximately 75% of available U.S.-marketed medical devices that are manufactured out of the country, and more specifically the 69% of available U.S.-marketed devices that are manufactured solely outside of the U.S., according to GlobalData's Medsource Database, which collates data on the medical device supply chain. These tariffs may have negative consequences for a continually growing market due to an ageing population and increasing prevalence of long-term illnesses. As a result of these policy changes, companies will be forced to increase prices to make up for losses incurred by the proposed tariffs. Additionally, this may cause supply chain disruptions, reducing accessibility to medical devices and inflating the cost of these products due to the higher demand in comparison to the supply.
